guidelines

visible & non-visible haematuria (assessment + referral)

practical gp guide: initial tests, safety-netting, and nice suspected-cancer referral thresholds for visible and non-visible haematuria.

last reviewed: 2026-02-13
based on: NICE NG12 (Suspected cancer: recognition and referral) + NICE CKS (urological cancers / haematuria) (accessed Feb 2026).

Executive summary (what to do today)

Haematuria is a symptom, not a diagnosis. The priority in primary care is to (1) identify emergencies, (2) exclude common reversible causes (UTI, stones, anticoagulation-related bleeding that still needs workup), and (3) use NICE NG12 thresholds for suspected cancer referral.

  • Visible haematuria (any frank blood) is higher-risk than isolated non-visible haematuria.
  • Never attribute haematuria solely to anticoagulants — anticoagulation can unmask pathology; the work-up is usually the same.
  • Always safety-net: persistent/recurrent haematuria, systemic symptoms, flank pain, anaemia, weight loss, or a palpable mass need escalation.

History + exam (red flags and common mimics)

  • Confirm it is urinary: menstruation/spotting, rectal bleeding, beetroot, rifampicin, phenazopyridine, myoglobin (rhabdo).
  • Symptoms: dysuria, frequency/urgency, loin pain, colicky pain (stones), fever/rigors (pyelo), LUTS, clot retention, trauma.
  • Risk factors: smoking, occupational exposure, pelvic irradiation, cyclophosphamide, recurrent UTIs, analgesic nephropathy, family history, schistosomiasis travel.
  • Examination: vitals, abdominal/flank tenderness, palpable bladder, genital exam (esp. men with scrotal/penile lesions), BP, signs of fluid overload/vasculitis.

Emergency features: haemodynamic instability, sepsis, clot retention (suprapubic pain + inability to pass urine), suspected obstructing stone with infection, or severe anaemia/syncope → same-day ED.

Investigations in primary care (minimum practical set)

  • Urine: dipstick (blood, protein, nitrite/leukocytes), send MSU if UTI symptoms, consider microscopy if persistent non-visible haematuria.
  • Bloods: FBC (anaemia), U&E/eGFR, CRP if infection suspected.
  • Proteinuric/renal pattern: check ACR (or PCR), BP, and consider glomerular causes if proteinuria, casts, or declining eGFR.
  • Imaging: do not delay referral if NG12 criteria met; imaging (e.g., renal US) is often arranged via urology pathways.

UTI scenario: treat per local antimicrobial guidance, then re-check if haematuria persists or recurs after treatment.

Referral thresholds (NICE NG12 – practical trigger list)

  • 2-week-wait urology: aged ≥45 with unexplained visible haematuria without UTI, or visible haematuria that persists/recurs after UTI treatment.
  • 2-week-wait urology: aged ≥60 with non-visible haematuria and either dysuria or raised WCC.
  • Nephrology/renal referral (often routine/urgent depending on severity): haematuria with significant proteinuria, declining eGFR, uncontrolled hypertension, or systemic features (e.g., vasculitis).

Safety-net wording: if haematuria recurs, if new clots/retention occurs, if fever/rigors develop, or if weight loss/night sweats/anaemia appear → urgent review.

FAQ

Transparency

This page is an educational, clinician-written summary of publicly available NICE guidance intended for trained healthcare professionals. It uses original wording (not copied text) and should be used alongside the full NICE source, local pathways, and clinical judgement. Doses provided are for general reference; always check the BNF/SPC.